Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Condition: Vasomotor SymptomsInterventions: Drug: Estradiol/DRSP (Angeliq, BAY86-4891); Drug: PlaceboSponsor: BayerCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2006 Category: Research Source Type: clinical trials